Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor
Clinical trial NCT03558945 · UNKNOWN
Trial details
- NCT number
- NCT03558945
- Sponsor
- Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-12
- Primary completion
- 2023-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.